CRISPR THERAPEUTICS AG (CRSP)
NASDAQ • Healthcare
Last close at August 11, 2026 at 20:00 UTC
Fundamentals Charts
About CRISPR THERAPEUTICS AG
CRISPR Therapeutics AG (NASDAQ: CRSP) is a biotechnology company focused on gene-edited medicines. In qualitative terms it is a clinical-stage healthcare business built around CRISPR/Cas9, which it uses to alter genetic code, with programs spanning ex vivo therapies, allogeneic CAR-T candidates, and stem cell-derived approaches.
Analyst Ratings
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Technical Indicators
CRISPR THERAPEUTICS AG's Technical Indicators Summary
CRSP is trading above its short- and medium-term moving averages and close to the 200-day level, supporting the buy case, while momentum indicators are favorable with a positive MACD and a strong CCI alongside a neutral-to-positive RSI. ADX points to modest trend strength rather than a pronounced trend, and volatility is moderate with ATR in the low single-digit percent range. On-balance volume shows accumulation despite a small negative reading, and the pivot is near current price. Technical takeaway: Buy bias.
| Indicator | Value |
|---|---|
RSI (14) | 58.41 |
Stochastic %K (14, 3, 3) | 88.80 |
CCI (20) | 121.89 |
WPR (14) | -13.25 |
Momentum (10) | 6.17 |
MFI | 72.14 |
MACD Level (12, 26) | 0.42 |
Bollinger Bands | $44.11 - $55.17 |
ATR (14) | $2.18 (4.05%) |
ADX (14) | 21.92 |
OBV | -6,441,891 |
Classic Pivot Point | $53.96 |
Fibonacci Pivot Point | $53.96 |
Exponential Moving Averages | $51.47 - $54.28(5 indicators) |
Simple Moving Averages | $49.64 - $53.36(5 indicators) |
Get premium market insights delivered directly to your inbox.
Today's Snapshot
A mild downside gap leaves CRSP -0.36% under yesterday’s close (54.07). Very little stock is changing hands, with volume stuck at 0.28× the everyday baseline. Stronger revenue and narrower loss could brighten CRSP's investment case.
Trading Volume
Below 10d avg (1.2M)
346.8K
vs S&P 500 Today
Underperforming Market
-0.61%
52-Week Position
Lower range
28.4%
Updated: August 12, 2026 at 17:15 UTC
Quote Summary
CRSP Headlines
Fresh Valuation Checks Across Key Stocks
April 4, 2026
Biotech ETFs Flash Classic Reversal Signal
April 1, 2026